Thomas Jefferson president has ‘liked’ tweets critical of COVID-19 vaccines, among other controversial topics - The Philadelphia Inquirer

korslapaja.blogspot.com Mark Tykocinski, the president of Thomas Jefferson University and dean of its medical college, has used his Twitt...

U.S. Covid-19 Deaths and Hospitalizations Near New Lows - The Wall Street Journal

korslapaja.blogspot.com Resume Subscription We are delighted that you'd like to resume your subscription. You will be charged $ + t...

Steady drip of COVID-19 cases continues in peloton - Cyclingnews

korslapaja.blogspot.com The steady drip of recent COVID-19 cases in the peloton continued on Friday with Warren Barguil (Arkéa-Samsic) th...

Is the new Covid-19 booster for you? Our medical analyst explains - CNN

korslapaja.blogspot.com CNN  —  Is it time for another Covid-19 vaccine booster? It’s the question many people are asking their doctors,...

Is the new Covid-19 booster for you? Our medical analyst explains - CNN

korslapaja.blogspot.com CNN  —  Is it time for another Covid-19 vaccine booster? It’s the question many people are asking their doctors,...

WHO watching XBB.1.16, dubbed Arcturus on social media, as a coronavirus variant of interest - CNN

korslapaja.blogspot.com CNN  —  The World Health Organization has elevated the fast-growing Omicron sublineage XBB.1.16 as a new variant...

Do I need a second Covid-19 booster? What to know about new FDA, CDC guidance. - Vox.com

korslapaja.blogspot.com The past three years have taught us a hard truth: Covid-19 doesn’t pose the same risk to everyone it infects. Now, ...

COVID-19 outbreak hits large Bay Area hospital, prompting new mask rules - San Francisco Chronicle

korslapaja.blogspot.com Physicians and staff at one of the Bay Area's largest hospitals are required to mask up again following a siza...

5 things to know for April 20: Tornadoes, Ukraine, Abortion, Covid-19, Facebook - CNN

korslapaja.blogspot.com CNN  —  Get '5 Things' in your inbox If your day doesn’t start until you’re up to speed on the latest...